IPSEN (IPN.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:IPN - FR0010259150 - Common Stock
120.6 EUR
-1.8 (-1.47%)
Taking everything into account, IPN scores 6 out of 10 in our fundamental rating. IPN was compared to 53 industry peers in the Pharmaceuticals industry. IPN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IPN scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings would make IPN suitable for value investing!
1. Profitability
1.1 Basic Checks
In the past year IPN was profitable.
IPN had a positive operating cash flow in the past year.
In the past 5 years IPN has always been profitable.
In the past 5 years IPN always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of IPN (6.56%) is comparable to the rest of the industry.
IPN has a Return On Equity (10.59%) which is comparable to the rest of the industry.
The Return On Invested Capital of IPN (14.88%) is better than 77.36% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IPN is in line with the industry average of 13.94%.
The 3 year average ROIC (12.97%) for IPN is below the current ROIC(14.88%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROIC | 14.88% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
1.3 Margins
The Profit Margin of IPN (11.91%) is comparable to the rest of the industry.
IPN's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 26.01%, IPN is doing good in the industry, outperforming 64.15% of the companies in the same industry.
IPN's Operating Margin has declined in the last couple of years.
The Gross Margin of IPN (83.32%) is better than 90.57% of its industry peers.
In the last couple of years the Gross Margin of IPN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% |
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IPN is creating value.
The number of shares outstanding for IPN has been increased compared to 1 year ago.
The number of shares outstanding for IPN remains at a similar level compared to 5 years ago.
The debt/assets ratio for IPN has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.46 indicates that IPN is not in any danger for bankruptcy at the moment.
IPN has a better Altman-Z score (4.46) than 62.26% of its industry peers.
The Debt to FCF ratio of IPN is 1.69, which is an excellent value as it means it would take IPN, only 1.69 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of IPN (1.69) is better than 88.68% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that IPN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.20, IPN is in the better half of the industry, outperforming 77.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Altman-Z | 4.46 |
ROIC/WACC1.9
WACC7.83%
2.3 Liquidity
A Current Ratio of 1.98 indicates that IPN should not have too much problems paying its short term obligations.
IPN has a better Current ratio (1.98) than 71.70% of its industry peers.
A Quick Ratio of 1.80 indicates that IPN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.80, IPN belongs to the top of the industry, outperforming 81.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.24% over the past year.
Measured over the past years, IPN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.79% on average per year.
The Revenue has grown by 9.45% in the past year. This is quite good.
Measured over the past years, IPN shows a small growth in Revenue. The Revenue has been growing by 5.83% on average per year.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
3.2 Future
Based on estimates for the next years, IPN will show a small growth in Earnings Per Share. The EPS will grow by 5.58% on average per year.
Based on estimates for the next years, IPN will show a small growth in Revenue. The Revenue will grow by 4.58% on average per year.
EPS Next Y9.37%
EPS Next 2Y3.92%
EPS Next 3Y4.54%
EPS Next 5Y5.58%
Revenue Next Year8.6%
Revenue Next 2Y6.18%
Revenue Next 3Y6.04%
Revenue Next 5Y4.58%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.74, which indicates a very decent valuation of IPN.
Based on the Price/Earnings ratio, IPN is valued a bit cheaper than 79.25% of the companies in the same industry.
IPN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.43.
With a Price/Forward Earnings ratio of 10.87, the valuation of IPN can be described as very reasonable.
Based on the Price/Forward Earnings ratio, IPN is valued a bit cheaper than 77.36% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of IPN to the average of the S&P500 Index (23.66), we can say IPN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.74 | ||
| Fwd PE | 10.87 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IPN is valued cheaper than 96.23% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IPN indicates a somewhat cheap valuation: IPN is cheaper than 62.26% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.6 | ||
| EV/EBITDA | 5.69 |
4.3 Compensation for Growth
IPN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of IPN may justify a higher PE ratio.
PEG (NY)1.25
PEG (5Y)1.34
EPS Next 2Y3.92%
EPS Next 3Y4.54%
5. Dividend
5.1 Amount
IPN has a Yearly Dividend Yield of 1.15%.
IPN's Dividend Yield is comparable with the industry average which is at 1.83.
Compared to the average S&P500 Dividend Yield of 1.87, IPN is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.15% |
5.2 History
The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
25.90% of the earnings are spent on dividend by IPN. This is a low number and sustainable payout ratio.
IPN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP25.9%
EPS Next 2Y3.92%
EPS Next 3Y4.54%
EPA:IPN (12/16/2025, 7:00:00 PM)
120.6
-1.8 (-1.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners15.21%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap10.11B
Revenue(TTM)3.76B
Net Income(TTM)447.90M
Analysts68.89
Price Target131.89 (9.36%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.15% |
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP25.9%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.12%
PT rev (3m)2.63%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.5%
EPS NY rev (3m)7.88%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)1.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.74 | ||
| Fwd PE | 10.87 | ||
| P/S | 2.69 | ||
| P/FCF | 19.6 | ||
| P/OCF | 11.27 | ||
| P/B | 2.39 | ||
| P/tB | 7.57 | ||
| EV/EBITDA | 5.69 |
EPS(TTM)10.27
EY8.52%
EPS(NY)11.09
Fwd EY9.2%
FCF(TTM)6.15
FCFY5.1%
OCF(TTM)10.71
OCFY8.88%
SpS44.86
BVpS50.46
TBVpS15.93
PEG (NY)1.25
PEG (5Y)1.34
Graham Number107.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROCE | 18.07% | ||
| ROIC | 14.88% | ||
| ROICexc | 20.46% | ||
| ROICexgc | 77.25% | ||
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% | ||
| FCFM | 13.72% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
ROICexc(3y)20.33%
ROICexc(5y)25.52%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.75%
ROCE(5y)18.64%
ROICexgc growth 3Y-59.92%
ROICexgc growth 5Y-22.83%
ROICexc growth 3Y-29.05%
ROICexc growth 5Y-11.89%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Debt/EBITDA | 0.5 | ||
| Cap/Depr | 55.54% | ||
| Cap/Sales | 10.15% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 53.9% | ||
| Profit Quality | 115.14% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 4.46 |
F-Score7
WACC7.83%
ROIC/WACC1.9
Cap/Depr(3y)131.36%
Cap/Depr(5y)124.73%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.18%
Profit Quality(3y)85.87%
Profit Quality(5y)89.99%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
EPS Next Y9.37%
EPS Next 2Y3.92%
EPS Next 3Y4.54%
EPS Next 5Y5.58%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
Revenue Next Year8.6%
Revenue Next 2Y6.18%
Revenue Next 3Y6.04%
Revenue Next 5Y4.58%
EBIT growth 1Y66.72%
EBIT growth 3Y-6.06%
EBIT growth 5Y1.3%
EBIT Next Year41.46%
EBIT Next 3Y13.73%
EBIT Next 5Y7.89%
FCF growth 1Y-33.64%
FCF growth 3Y-35.67%
FCF growth 5Y-17.46%
OCF growth 1Y-8.92%
OCF growth 3Y-0.07%
OCF growth 5Y7.84%
IPSEN / IPN.PA FAQ
What is the fundamental rating for IPN stock?
ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.
Can you provide the valuation status for IPSEN?
ChartMill assigns a valuation rating of 7 / 10 to IPSEN (IPN.PA). This can be considered as Undervalued.
Can you provide the profitability details for IPSEN?
IPSEN (IPN.PA) has a profitability rating of 6 / 10.
What is the earnings growth outlook for IPSEN?
The Earnings per Share (EPS) of IPSEN (IPN.PA) is expected to grow by 9.37% in the next year.
Can you provide the dividend sustainability for IPN stock?
The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 25.9%.